Aug '22
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") reports that its shareholders voted in favour of all resolutions presented at its annual and special meeting held today at 10:00 am PT.
The...
Aug '22
Emerald Health Therapeutics, Inc. Provides Update on and Additional Background to Transaction with Skye Bioscience
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing an update and additional background on its transaction (the "Transaction") with Skye Bioscience Inc. (OTCQB: SKYE) ("Skye")...
Aug '22
Emerald Health Therapeutics, Inc. Restates Q1 Financial Statements to Meet PCAOB Standard
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announces that it has identified matters which require the Company to make restatements (the "Restatements") in respect of its interim...
Jul '22
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - July 12, 2022) - Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (CSE: EMH) (OTCQB: EMHTF) reports that it has received an Order of the British Columbia Securities Commission ("BCSC") revoking the management cease trade order ("MCTO")...
Jul '22
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") has reported financial results for the quarter ended March 31, 2021.
Through the first quarter of 2022 the Company continued to execute on its...